3상모집 중
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
연구 개요
ALLTogether collects the experience of previously successful treatment of infants, children and young adults, with ALL from a number of well-renowned study groups into a new master protocol, which is both a comprehensive system for stratification and treatment of ALL in this age-group as well as the basis for several randomised and interventional trials included in the study-design.
- 스폰서
- 협력: 암젠, 화이자
- 적응증
- Leukemia, Acute Lymphoblastic
- 중재
- Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab Ozogamicin+Standard Maintenance Therapy, Imatinib, 6-tioguanine+Standard Maintenance Therapy, Blinatumomab
- 목표 등록
- 6,430명
- 시작일
- 2020-07-13
- 완료(예정)
- 2033-06-01
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.